P-53 Efficacy and safety of ravulizumab in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: Outcomes from the phase 3 CHAMPION-NMOSD trial
Gespeichert in:
| Veröffentlicht in: | Clinical neurophysiology Jg. 148; S. e32 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Elsevier B.V
01.04.2023
|
| Schlagworte: | |
| ISSN: | 1388-2457, 1872-8952 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Author | Berthele, A. de Sèze, J. Nakashima, I. Oreja-Guevara, C. Paul, F. Mashhoon, Y. Yountz, M. Kim, H.J. Pittock, S. Palace, J. Pozzilli, C. Levy, M. Bennett, J.L. Barnett, M. Allen, K. |
|---|---|
| Author_xml | – sequence: 1 givenname: S. surname: Pittock fullname: Pittock, S. organization: Department of Neurology, Center MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA – sequence: 2 givenname: M. surname: Barnett fullname: Barnett, M. organization: Brain and Mind Centre, University of Sydney, NSW, Australia – sequence: 3 givenname: J.L. surname: Bennett fullname: Bennett, J.L. organization: Departments of Neurology and Ophthalmology, Programs in Neuroscience and Immunology, University of Colorado, Aurora, CO, USA – sequence: 4 givenname: A. surname: Berthele fullname: Berthele, A. organization: Department of Neurology, School of Medicine, Technical University of Munich, Munich, Germany – sequence: 5 givenname: J. surname: de Sèze fullname: de Sèze, J. organization: Department of Neurology and Clinical Investigation Center, CHU de Strasbourg, France – sequence: 6 givenname: M. surname: Levy fullname: Levy, M. organization: Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA – sequence: 7 givenname: I. surname: Nakashima fullname: Nakashima, I. organization: Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan – sequence: 8 givenname: C. surname: Oreja-Guevara fullname: Oreja-Guevara, C. organization: Department of Neurology, Hospital Clínico Universitario San Carlos, Idissc, Madrid, Spain – sequence: 9 givenname: J. surname: Palace fullname: Palace, J. organization: Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK – sequence: 10 givenname: F. surname: Paul fullname: Paul, F. organization: Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité – Universitaetsmedizin Berlin, Berlin, Germany – sequence: 11 givenname: C. surname: Pozzilli fullname: Pozzilli, C. organization: NCL, Institute of Neurological Science, Rome, Italy – sequence: 12 givenname: K. surname: Allen fullname: Allen, K. organization: Alexion, AstraZeneca Rare Disease, Boston, MA, USA – sequence: 13 givenname: Y. surname: Mashhoon fullname: Mashhoon, Y. organization: Alexion, AstraZeneca Rare Disease, Boston, MA, USA – sequence: 14 givenname: M. surname: Yountz fullname: Yountz, M. organization: Alexion, AstraZeneca Rare Disease, Boston, MA, USA – sequence: 15 givenname: H.J. surname: Kim fullname: Kim, H.J. organization: Department of Neurology, National Cancer Center, Goyang, South Korea |
| BookMark | eNqVUdFu1DAQjFCRaAt_wMP-gIPtJJcEIaTqKLRS26tUeLYce63zkcTBdg6Fr-ITcTheEeJpvdbM7O7MRXY2uhGz7DWjOaNs8-aQq96O0z7nlBc55Tmt6bPsnDU1J01b8bP0LpqG8LKqX2QXIRwoTZCSn2c_H0lVwLUxVkm1gBw1BGkwLuAMeHmce_tjHmQHdgSp5z4G-G7jPgGjJfLbLCfn7UjK3x-d0wuZXLDRHhFGnL0bFuxTG8BNMY2AMKGKfh5A2-C8Rv8WdnNUbsAAJsEh7hGmvQwIBWxvru4fb3cP5OF-9_QBoreyf5k9N7IP-OpPvcy-fLz-vL0hd7tPt9urO6I4bSjRG6lKVSjFS93VpWlk1zRGb3hNsWK6VYyXptWGtoY1tGYF1Qor3iFFU2i1KS6z8qSrvAvBoxGTt4P0i2BUrK6Lgzi5LlbXBeUiWZpo7080TLsdLXoRlMVRobY-XS60s_8rsIKSdf1XXDAc3OzHdLdgIiSCeFqDXXPlRcq0rcsk8O7vAv-e_wtukLuV |
| ContentType | Journal Article |
| Copyright | 2023 |
| Copyright_xml | – notice: 2023 |
| DBID | AAYXX CITATION |
| DOI | 10.1016/j.clinph.2023.02.070 |
| DatabaseName | CrossRef |
| DatabaseTitle | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1872-8952 |
| EndPage | e32 |
| ExternalDocumentID | 10_1016_j_clinph_2023_02_070 S1388245723000974 1_s2_0_S1388245723000974 |
| GroupedDBID | --- --K --M -~X .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29B 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 71M 8P~ AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABFNM ABFRF ABIVO ABJNI ABLJU ABMAC ABMZM ABTEW ABWVN ABXDB ACDAQ ACGFO ACIEU ACIUM ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGWIK AGYEJ AI. AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HX~ HZ~ IHE J1W K-O KOM L7B M41 MO0 MOBAO MVM N9A O-L O9- OAUVE OHT OP~ OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSN SSZ T5K UAP UNMZH UV1 VH1 X7M XOL XPP Z5R ZGI ~G- ~HD AACTN AFCTW AFKWA AJOXV AMFUW PKN RIG VQA AADPK AAIAV ABLVK ABYKQ AFMIJ AHPSJ AJBFU LCYCR ZA5 9DU AAYXX CITATION |
| ID | FETCH-LOGICAL-c2080-d6ac4c3cc24db74f8ab88fd6270e51d9c124f9df09f1807130dce52be0ef3dc63 |
| ISSN | 1388-2457 |
| IngestDate | Sat Nov 29 07:03:01 EST 2025 Fri Feb 23 02:38:24 EST 2024 Sun Feb 23 10:18:48 EST 2025 Tue Oct 14 19:38:53 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c2080-d6ac4c3cc24db74f8ab88fd6270e51d9c124f9df09f1807130dce52be0ef3dc63 |
| ParticipantIDs | crossref_primary_10_1016_j_clinph_2023_02_070 elsevier_sciencedirect_doi_10_1016_j_clinph_2023_02_070 elsevier_clinicalkeyesjournals_1_s2_0_S1388245723000974 elsevier_clinicalkey_doi_10_1016_j_clinph_2023_02_070 |
| PublicationCentury | 2000 |
| PublicationDate | April 2023 |
| PublicationDateYYYYMMDD | 2023-04-01 |
| PublicationDate_xml | – month: 04 year: 2023 text: April 2023 |
| PublicationDecade | 2020 |
| PublicationTitle | Clinical neurophysiology |
| PublicationYear | 2023 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| SSID | ssj0007042 |
| Score | 2.4061286 |
| SourceID | crossref elsevier |
| SourceType | Index Database Publisher |
| StartPage | e32 |
| SubjectTerms | Neurology |
| Title | P-53 Efficacy and safety of ravulizumab in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: Outcomes from the phase 3 CHAMPION-NMOSD trial |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1388245723000974 https://www.clinicalkey.es/playcontent/1-s2.0-S1388245723000974 https://dx.doi.org/10.1016/j.clinph.2023.02.070 |
| Volume | 148 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1872-8952 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007042 issn: 1388-2457 databaseCode: AIEXJ dateStart: 20180601 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZKhxAviKsYN_mBtyhVGufKW1WGBqJdpQ5pb5ZjO6LTmoamrTZ-Fb-DX8WxHafpOjH2wEtUWbHj5Pt6fHx8Lgi9h1UsVRWj3dhnzA1C7rmg5atdawbKfr8vmCd0sYl4PE7OztJJp_PbxsJsLuKiSC4v0_K_Qg1tALYKnb0D3M2g0AC_AXS4Auxw_SfgJ25IVMFk-PrcJFeqWC6N48WSbdYXs5_rOcuUoUMn32ji21Yzl_1Ys1K55LmBbsgW4so1fl0b6ejcl_MrqTzmKmdRKjO4o0M1l-u5OurReTyVjeFkvYJXk9U2eqX8DsulQ5zh8WA0UfJ7PDqZfnR00ZC2gjy0kZr6YdrusmP4n8xWq1qET3tbM-yyqP2NR9tGHXFkjlp6X1vNS5iPcaIe9NpGD5-0fGWMnCYK9cDktm4EucnZWYtiaeyme0uEsVac91TkaamOo3yis7aa-iW7GbmvrZSN_6J1jTunZhSqRqGeT2GUe-jAj8M06aKDweejsy-NXhB7upRTM3UbyKm9Dfdnc7Oi1FJ-Th-jR_WuBQ8M256gjiyeogej2i_jGfqlSIct6TCQDhvS4UWOW6TDswIb0mFFOnyddHiPdHiHdNiQDlvSYUu6D9hSDivKYYAYa8phgncphzXlnqNvn45Oh8duXQvE5T5salwRMR5wwrkfiCwO8oRlSZKLyI89GfZFykFPzVORe2neT5TlxRNchn4mPZkTwSPyAnWLRSFfqiwFCWGRyLwkzwMWk1RkYR5GSZRmsBsQ3iFy7YenpUn5Qv8G-CEKLTrUhjPDAkyBcLf0i2_qJ6tamFS0Tyu4k04VZRRjfKLjroJ2z1pRNgrwrc98dcd3e40ebv9-b1AXoJVv0X2-AciX72qG_wFfJ-UM |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=P-53+Efficacy+and+safety+of+ravulizumab+in+adults+with+anti-aquaporin-4+antibody-positive+neuromyelitis+optica+spectrum+disorder%3A+Outcomes+from+the+phase+3+CHAMPION-NMOSD+trial&rft.jtitle=Clinical+neurophysiology&rft.au=Pittock%2C+S.&rft.au=Barnett%2C+M.&rft.au=Bennett%2C+J.L.&rft.au=Berthele%2C+A.&rft.date=2023-04-01&rft.issn=1388-2457&rft.volume=148&rft.spage=e32&rft_id=info:doi/10.1016%2Fj.clinph.2023.02.070&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_clinph_2023_02_070 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F13882457%2FS1388245723X00030%2Fcov150h.gif |